ProCE Banner Activity

Expert Commentary and Insight on Key Data From the 2023 ASCO Annual Meeting Informing Treatment for Endometrial, Cervical, and Ovarian Cancers

Conference Coverage
Clinical Thought

In this commentary, Kathleen Moore, MD, and Nicoletta Colombo, MD, PhD, share their thoughts on key new data for gynecologic cancers presented at the 2023 ASCO Annual Meeting, including new clinical trial results for endometrial, cervical, and ovarian cancers.

Released: June 29, 2023

Share

Faculty

Nicoletta Colombo

Nicoletta Colombo, MD, PhD

Associate Professor of Obsterics and Gynecology
European Institute of Oncology 
University of Milan-Bicocca
Milan, Italy  

Kathleen N. Moore

Kathleen N. Moore, MD, MS, FASCO

Virginia Kerley Cade Chair in Developmental Therapeutics
Deputy Director, Stephenson Cancer Center at OU Health
Oklahoma City, Oklahoma

Provided by

Provided by Clinical Care Options (CCO)

ProCE Banner

Supporters

This educational activity is supported by educational grants from AstraZeneca, GlaxoSmithKline, Merck Sharp & Dohme Corp, Novocure, Genmab and Seagen.

AstraZeneca

Genmab

GlaxoSmithKline

Merck Sharp & Dohme Corp.

Novocure

Seagen

Faculty Disclosure

Primary Author

Nicoletta Colombo, MD, PhD

Associate Professor of Obsterics and Gynecology
European Institute of Oncology 
University of Milan-Bicocca
Milan, Italy  

Nicoletta Colombo, MD: consultant/advisor/speaker: AstraZeneca, Clovis, Eisai, GlaxoSmithKline, Immunogen Merck Sharp & Doheme, Mersana, Nuvation, Oncxerna, Pfizer, Pieris, Roche.

Kathleen N. Moore, MD, MS, FASCO

Virginia Kerley Cade Chair in Developmental Therapeutics
Deputy Director, Stephenson Cancer Center at OU Health
Oklahoma City, Oklahoma

Kathleen Moore, MD, MS: consultant/advisor/speaker: Aadi, AstraZeneca, Aravive, Alkermes, Blueprint Pharma, Caris, Clovis, Eisai, Genentech, GlaxoSmithKline, Immunogen, Inxmed, Imab, Janssen, Lilly, Merck, Mereo, Mersana, Myriad, Novartis, Onconova, Oncxerna, Pannavance, Regeneron, VBL Therapeutics, Verastem, Zentalis; independent contractor: GOG Partners Associate Director.